Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysis.

Rivera, Frederick Berro; Tang, Vincent Anthony S; De Luna, Deogracias Villa; Lerma, Edgar V; Vijayaraghavan, Krishnaswami; Kazory, Amir; Shah, Nilay S; Volgman, Annabelle Santos

Rivera, Frederick Berro; Tang, Vincent Anthony S; De Luna, Deogracias Villa; Lerma, Edgar V; Vijayaraghavan, Krishnaswami; Kazory, Amir; Shah, Nilay S; Volgman, Annabelle Santos.

Affiliation

Rivera FB; Department of Medicine, Lincoln Medical Center, Bronx, NY, USA.
Tang VAS; Department of Medicine, University of the Philippines - Philippine General Hospital, Metro Manila, Philippines.
De Luna DV; Department of Internal Medicine, Danbury Hospital, Danbury, CT, USA.
Lerma EV; Section of Nephrology, University of Illinois at Chicago College of Medicine/Advocate Christ Medical Center Oak Lawn, IL, USA.
Vijayaraghavan K; University of Arizona, AZ, USA.
Kazory A; Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, FL, USA.
Shah NS; Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Volgman AS; Division of Cardiology, Rush University Medical Center, Chicago, IL, USA.

Am Heart J Plus ; 262023 Feb.

Article de En | MEDLINE | ID: mdl-37305172

Mots clés

Cardiorenal; Cardiovascular outcomes; Heart failure; SGLT-2 inhibitors; Sex differences

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Systematic_reviews Langue: En Journal: Am Heart J Plus Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google